CTNNB1 and necrotizing enterocolitis: In another study using a mouse model of NEC, enteral recombinant lactoferrin administration (6 g/L) prevented a NEC protocol induced decrease in Ki67 immunoreactivity, preserved beta-catenin immunoreactivity and restored LGR5 mRNA levels in the distal ileum [101].